purified and cloned differentiation-stimulating factor (D-factor)/leukemia inhibitory factor as a cytokine inducing differentiation of mouse myeloid leukemia Ml-T22 cells into macrophages. We found recently that injections of recombinant mouse D-factor prolonged the survival times of mice implanted with the M1-T22 cells4 and that human D-factor suppressed the proliferation of freshly isolated leukemic blast cells from acute myeloblastic leukemia patient^.^ These results suggest that D-factor is of potential value in the therapy of myeloid leukemia. However, D-factor stimulates the proliferation of some leukemic cell lines, such as mouse DA-la6 and human TFl.' Furthermore, it has a wide variety of biologic activities besides its actions on normal and leukemic hematopoietic c e k 8
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To determine whether D-factor can induce the differentiation of leukemic cells other than Ml-T22 cells, we cloned a cDNA encoding mouse D-factor receptor" and introduced the D-factor receptor into WEHI-3B D+ mouse myelomonocytic leukemia cells, which were induced to differentiate by IL-6 or granulocyte colony-stimulating factor (G-CSF), but not D-fa~tor.'~.'~ We show here that D-factor and OSM induce differentiation and suppress proliferation of WEHI-3B D+ cells transfected with D-factor receptor cDNA.
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MATERIALS AND METHODS
Cells and cell culture. WEHI-3B D+ leukemia cells (kindly provided by Dr Alan C. Sartorelli, Yale University School of Medicine, New Haven, CT) were cultured in McCoy's 5A modified medium (GIBCO-BRL, Grand Island, NY) supplemented with 10% (v& vol) heat-inactivated fetal calf serum (FCS; GIBCO BRL or Flow Laboratories, Stanmore, Australia) in an atmosphere of 5% CO2 in air at 37°C. Myeloid leukemic M1 cells were cultured as described previously.' Clone T-22 cells can be induced to differentiate by Dfactor, but clone R-4 cells can not.
Cytokines. Recombinant mouse D-factor was produced in Chinese hamster ovary cells and recombinant human G-CSF was produced in Escherichia coli and purified to homogeneity as described p r e v i o~s l y .~.~~. '~ Recombinant human IL-6 was kindly provided by Ajinomoto CO (Kawasaki, Japan). Recombinant human OSM and IL-11 were purchased from R & D Systems, Minneapolis, MN.
Plasmid construction. Mouse cDNAs encoding the membrane receptor and the soluble receptor for D-factor were cloned from a cDNA library prepared from the liver of a pregnant mouse as described previously.12 The full length of cDNA encoding the membrane receptor was prepared by recombination of the LS 1 clone and LS3 clone (in Fig 2A of reference 12 ) at the Tthl11I restriction site. The cDNA was subcloned into the Eco R1 site of the expression vector, pSG5 (Stratagene, La Jalla, CA), which includes the SV40 early promotor. It was confirmed that the cDNA was functional, by transient expression of the cDNA in COS-7 cells. The binding of ['ZSI]D-factor to COS-7 cells increased 80-fold after transfection of the cDNA into the cells.
Transfection of DNA. DNA was introduced into WEHI-3B cells by electroporation using the Gene Pulser (Bio-Rad Laboratories, Richmond, CA). The cells (1 X 10') were suspended in 0.8 mL of HEPES-buffered saline (50 mmol/L HEPES, 137 mrnoi/L NaCI, 6.8 mmoVL KCI, 0.28 mmoVL Na2HP04, and 0.1% dextrose, pH 7.1) containing 20 pg of linearized expression plasmid and 1 pg of pXTl (Stratagene) conferring neomycin resistance, and incubated on ice for 15 minutes. The cells were exposed to a 450 V pulse with a capacitance of 960 pF, and returned to ice. After incubation on ice Cells (lo6 in 0.5 mL) were incubated with I'2511D-factor (5 ng) for 3 hours at room temperature. Specific binding was determined by subtracting the binding in the presence of 60-fold excess of unlabeled D-factor. NBT-reducing cells were determined by the microscopic assay after treatment of the cells with or without 10 kg/mL of D-factor for 3 days. The cells were treated with D-factor the next day on which D-factor binding was determined.
Abbreviation: ND, not determined.
* Each value is the mean of duplicate determinations f SE.
for 5 minutes, the cells were cultured in 20 mL medium for 2 days. The cells were transferred into 96-well plates and cultured in medium containing G-418 at the final concentration of 2 mg/mL.
Cellular binding of ['2'r]D-factor. Iodination of mouse D-factor
with chloramine-T and assay of cellular binding of [12SI]D-factor were performed as described previously.'6 The specific radioactivity of the [lZ'I]D-factor preparation was 3.4 X 10' counts per minute (cpm)/ng protein.
Properties of differentiated cells. The ability of cells to reduce nitroblue tetrazolium (NBT) was used as a functional marker of differentiation. Cell numbers were determined using a Model ZM Coulter Counter (Coulter Electronics, Luton, UK). One X lo6 cells were incubated in 1 mL of serum-free medium containing 0.1% NBT and 100 ng/mL of 12-0-tetradecanoylphorbol 13-acetate at 37°C for 30 minutes. In the microscopic assay, the percentage of cells with blue-black formazan deposit was determined by examination of a minimum of 200 cells. In the colorimetric assay, the reaction was stopped by adding HCl to the final concentration of 1 m o a . The suspension was centrifuged and the formazan deposits were solubilized by adding dimethyl sulfoxide. The absorption of the formazan solution at 560 nm was measured with a spectrophotometer (U-2000, Hitachi, Tokyo). Expression of the granulocyte-and macrophage-specific antigen Mac-l (CD1 lb) on the cell surface was determined by indirect immunofluorescent staining and flow cytometry as described previously." The cells (2 X 10') were washed with phosphate-buffered saline (PBS) and incubated in 50 pL of rat anti-Mac-l monoclonal antibody (diluted 1:20; Boehringer Mannheim Biochemica, Indianapolis, IN) in PBS containing 0.1% bovine serum albumin (BSA) on ice for 30 minutes. Then the cells were washed and stained in 50 pL of phycoerythrin-conjugated goat-antirat IgG antibody (diluted 1:20; Cedar Lane, Ontario, Canada) in PBS containing 0.1% of BSA on ice for 30 minutes. The cells were washed, then analyzed in an Epics Elite flow cytometer (Coulter Electronics). (Fig 2) .
RESULTS
Establishment of cell lines expressing the D-
The induction of differentiation of the transfected cells accompanied a decrease in cell number. The cell number of clones DR1, DR2, DR4, and DR6 treated with D-factor for 3 days was 70% to 80% of that of the control culture. The growth rates of clones DR3, DR8, and Neo were not changed by treatment of the cells with D-factor. Figure 3 shows the effect of D-factor on proliferation of DR2 cells. Treatment of the cells with D-factor for longer than 5 days resulted in 50% inhibition of growth. A similar inhibitory effect of Dfactor on the proliferation of DR1 cells was observed (data no shown).
Next, the effects of several cytokines, which induced differentiation of mouse myeloid leukemia M1 cells, on the WEHI-3B cells transfected with D-factor receptor cDNA were examined. Results are shown in Table 2 . DRl, DR2, and DR6 are D-factor-sensitive clones, whereas DR8, Neo, and parental WEHI-3B are not. All clones responded to IL-6. IL-6 is the most effective inducer against parental WEHI-3B and the cells transfected with neomycin resistance gene alone (Neo). Parental WEHI-3B cells responded poorly if at all to the inducing activity of G-CSF in liquid culture as reported by Li et Some clones, which responded to Dfactor, were more sensitive to G-CSF, as compared with the parental cells. The sensitivity to IL-l1 was varied among these clones. The sensitivity to OSM was identical to that against D-factor in the cells of each clone. The growth inhibition was also observed in clones that were induced to differentiate by OSM. Effects of various concentrations of Dfactor or OSM on clones DR1 and DR2 were examined. Figure 4 shows both D-factor and OSM induced the differentiation of DR1 cells in a similar dose-dependent manner. Both cytokines were effective at concentrations higher than 0.5 ng/mL. The stimulating effects of both cytokines were saturated at concentrations lower than 5 ng/mL. K-6, IL-1 1, and G-CSF were more effective at the concentration of 100 ng/mL than at 10 ng/mL (data not shown). All three transfected WEHI-3B clones, which expressed a higher number of D-factor receptors than those of Ml-T22 cells, were sensitive to D-factor (Table 1) . On the other hand, all transfected clones examined, which showed lower capacity of D-factor-binding than that of DR8 clone, could not be induced to differentiate by D-factor (data not shown). Therefore, the level of D-factor receptor expression in these leukemia cells seemed to be important for a response to D-
Days of treatment For We previously showed that D-factor is a potent inducer of differentiation of Ml-T22 cells and that G-CSF is a weak inducer for the cells.'.15 Combination of G-CSF with D-factor resulted in synergistic stimulation of differentiation?" IL-6 and OSM also induced differentiation of Ml-T22 cells." Although IL-l1 and IL-6 showed the same effect in many cases, IL-11 did not induce the differentiation of the cells (unpublished results, December 1992). Rose and Bruce" compared the structure of the proteins and genes of D-factor, OSM, IL-6, and G-CSF and suggested that these four cytokines have evolved from a common ancestor and are members of a single cytokine family. Furthermore, receptors for D-factor, OSM, IL-6, and IL-11 share a signal transduction subunit, gp130." On the other hand, IL-6 and G-CSF, but not D-factor, induce the differentiation of parental WEHI-3B cells.'-7314 Transfected WEHI-3B cells with D-factor receptor cDNA respond to D-factor, OSM, IL-6, and G-CSF ( Table  2) . Some transfected clones, but not all clones, responded to IL-11. Expression of D-factor receptor in WEHI-3B cells promoted the sensitivity to L -6 and G-CSF and a small portion of these cells had the ability to reduce NBT in the 
